Schrödinger, Inc. (NASDAQ:SDGR - Get Free Report) was down 5.4% during mid-day trading on Tuesday . The stock traded as low as $22.14 and last traded at $22.44. Approximately 224,873 shares traded hands during mid-day trading, a decline of 70% from the average daily volume of 744,017 shares. The stock had previously closed at $23.73.
Analysts Set New Price Targets
Several analysts have recently issued reports on SDGR shares. Piper Sandler lowered their price target on shares of Schrödinger from $50.00 to $45.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. KeyCorp upped their target price on shares of Schrödinger from $25.00 to $27.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. One investment analyst has rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Buy" and an average price target of $32.29.
Check Out Our Latest Research Report on Schrödinger
Schrödinger Stock Performance
The firm has a market cap of $1.59 billion, a PE ratio of -9.32 and a beta of 1.62. The stock's 50 day simple moving average is $22.92 and its 200 day simple moving average is $20.77.
Schrödinger (NASDAQ:SDGR - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The company reported ($0.55) EPS for the quarter, missing analysts' consensus estimates of ($0.35) by ($0.20). Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The company had revenue of $88.32 million during the quarter, compared to analysts' expectations of $83.20 million. As a group, analysts anticipate that Schrödinger, Inc. will post -2.37 earnings per share for the current year.
Insiders Place Their Bets
In other news, CFO Geoffrey Craig Porges sold 5,491 shares of the company's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $21.76, for a total value of $119,484.16. Following the completion of the sale, the chief financial officer now owns 27,544 shares of the company's stock, valued at approximately $599,357.44. This represents a 16.62 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 8.60% of the company's stock.
Institutional Investors Weigh In On Schrödinger
A number of institutional investors have recently made changes to their positions in the business. United Advisor Group LLC boosted its stake in shares of Schrödinger by 3.3% in the 4th quarter. United Advisor Group LLC now owns 19,769 shares of the company's stock valued at $381,000 after purchasing an additional 634 shares in the last quarter. KBC Group NV boosted its position in Schrödinger by 45.4% during the 3rd quarter. KBC Group NV now owns 2,508 shares of the company's stock valued at $47,000 after buying an additional 783 shares during the period. Redwood Wealth Management Group LLC boosted its position in Schrödinger by 8.4% during the 4th quarter. Redwood Wealth Management Group LLC now owns 14,620 shares of the company's stock valued at $283,000 after buying an additional 1,132 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Schrödinger by 3.9% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 31,643 shares of the company's stock worth $610,000 after purchasing an additional 1,202 shares in the last quarter. Finally, GAMMA Investing LLC raised its holdings in Schrödinger by 87.5% in the 4th quarter. GAMMA Investing LLC now owns 2,796 shares of the company's stock worth $54,000 after purchasing an additional 1,305 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.
About Schrödinger
(
Get Free Report)
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
See Also
Before you consider Schrödinger, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrödinger wasn't on the list.
While Schrödinger currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
